Semler Scientific/SMLR

$25.85

0.74%
-
1D1W1MYTD1YMAX

About Semler Scientific

Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.

Ticker

SMLR

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Douglas Murphy-Chutorian

Employees

92

Headquarters

Santa clara, United States

SMLR Metrics

BasicAdvanced
$181.26M
Market cap
9.81
P/E ratio
$2.63
EPS
0.92
Beta
-
Dividend rate
$181.26M
0.91569
$53.38
$22.82
77.64K
10.636
10.564
6.095
29.25%
32.29%
32.24%
9.811
2.658
2.472
2.525
8.841
20.28%
45.96%
20.88%
14.88%

What the Analysts think about SMLR

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 1 analyst.
151.45% upside
High $65.00
Low $65.00
$25.85
Current price
$65.00
Average price target

SMLR Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
28% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$15M
-7.98%
Net income
$4.2M
-23.64%
Profit margin
28%
-17.01%

SMLR Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 3.51%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.63
$0.75
$0.71
$0.59
-
Expected
$0.58
$0.56
$0.51
$0.57
$1.03
Surprise
8.62%
33.93%
39.22%
3.51%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Semler Scientific stock?

Semler Scientific (SMLR) has a market cap of $181.26M as of April 18, 2024.

What is the P/E ratio for Semler Scientific stock?

The price to earnings (P/E) ratio for Semler Scientific (SMLR) stock is 9.81 as of April 18, 2024.

Does Semler Scientific stock pay dividends?

No, Semler Scientific (SMLR) stock does not pay dividends to its shareholders as of April 18, 2024.

When is the next Semler Scientific dividend payment date?

Semler Scientific (SMLR) stock does not pay dividends to its shareholders.

What is the beta indicator for Semler Scientific?

Semler Scientific (SMLR) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Semler Scientific stock price target?

The target price for Semler Scientific (SMLR) stock is $65, which is 156.11% above the current price of $25.38. This is an average based on projections from 1 analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Semler Scientific stock

Buy or sell Semler Scientific stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing